What is Myriad Genetics's other commercial liabilities?

Myriad Genetics (MYGN) reported other commercial liabilities of $90.5M in Q1 2026.

How has Myriad Genetics's other commercial liabilities changed year-over-year?

Myriad Genetics's other commercial liabilities decreased by 19.3% year-over-year, from $112.1M to $90.5M.

What is the long-term trend for Myriad Genetics's other commercial liabilities?

Over 5 years (2020 to 2025), Myriad Genetics's other commercial liabilities has grown at a 4.1% compound annual growth rate (CAGR), from $79.1M to $96.9M.

Myriad Genetics MYGN Other Commercial Liabilities

Other Commercial Liabilities at other companies

Labcorp HoldingsLH

——

VeracyteVCYT

——

Guardant HealthGH

——

Fulgent Genetics, Inc.FLGT

——

Tempus AI, Inc.TEM

——

GeneDx HoldingsWGS

——

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total equity$337.4M-52.1%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Free cash flow-$19.7M+65.1%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

P/S0.6×+0.1×

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's other commercial liabilities?: Myriad Genetics (MYGN) reported other commercial liabilities of $90.5M in Q1 2026.
How has Myriad Genetics's other commercial liabilities changed year-over-year?: Myriad Genetics's other commercial liabilities decreased by 19.3% year-over-year, from $112.1M to $90.5M.
What is the long-term trend for Myriad Genetics's other commercial liabilities?: Over 5 years (2020 to 2025), Myriad Genetics's other commercial liabilities has grown at a 4.1% compound annual growth rate (CAGR), from $79.1M to $96.9M.